Silverfin false 31/12/2022 01/01/2022 31/12/2022 J Kirkbride 29/09/2021 B Lampl 28/05/2021 04 October 2023 The principal activity of the company during the financial year was production and manufacture of anaesthetic medical supplies. The company commenced trading on 20 January 2022. 13427910 2022-12-31 13427910 bus:Director1 2022-12-31 13427910 bus:Director2 2022-12-31 13427910 2021-12-31 13427910 core:CurrentFinancialInstruments 2022-12-31 13427910 core:CurrentFinancialInstruments 2021-12-31 13427910 core:ShareCapital 2022-12-31 13427910 core:ShareCapital 2021-12-31 13427910 core:RetainedEarningsAccumulatedLosses 2022-12-31 13427910 core:RetainedEarningsAccumulatedLosses 2021-12-31 13427910 core:PlantMachinery 2021-12-31 13427910 core:FurnitureFittings 2021-12-31 13427910 core:PlantMachinery 2022-12-31 13427910 core:FurnitureFittings 2022-12-31 13427910 2022-01-01 2022-12-31 13427910 bus:FullAccounts 2022-01-01 2022-12-31 13427910 bus:SmallEntities 2022-01-01 2022-12-31 13427910 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 13427910 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 13427910 bus:Director1 2022-01-01 2022-12-31 13427910 bus:Director2 2022-01-01 2022-12-31 13427910 core:PlantMachinery 2022-01-01 2022-12-31 13427910 core:FurnitureFittings 2022-01-01 2022-12-31 13427910 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure

Company No: 13427910 (England and Wales)

HYPNEUMA LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2022
Pages for filing with the registrar

HYPNEUMA LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2022

Contents

HYPNEUMA LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2022
HYPNEUMA LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2022
DIRECTORS J Kirkbride
B Lampl
REGISTERED OFFICE The Health And Wellbeing Innovation Centre
Treliske
Truro
TR1 3FF
United Kingdom
COMPANY NUMBER 13427910 (England and Wales)
CHARTERED ACCOUNTANTS Francis Clark LLP
Lowin House
Tregolls Road
Truro
Cornwall TR1 2NA
HYPNEUMA LIMITED

BALANCE SHEET

As at 31 December 2022
HYPNEUMA LIMITED

BALANCE SHEET (continued)

As at 31 December 2022
Note 2022 2021
£ £
Fixed assets
Tangible assets 3 13,041 0
13,041 0
Current assets
Stocks 1,000 60
Debtors 4 99,248 12
Cash at bank and in hand 7,733 2,997
107,981 3,069
Creditors: amounts falling due within one year 5 ( 49,832) ( 62,278)
Net current assets/(liabilities) 58,149 (59,209)
Total assets less current liabilities 71,190 (59,209)
Provision for liabilities ( 3,260) 0
Net assets/(liabilities) 67,930 ( 59,209)
Capital and reserves
Called-up share capital 2 2
Profit and loss account 67,928 ( 59,211 )
Total shareholders' funds/(deficit) 67,930 ( 59,209)

For the financial year ending 31 December 2022 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hypneuma Limited (registered number: 13427910) were approved and authorised for issue by the Board of Directors on 04 October 2023. They were signed on its behalf by:

B Lampl
Director
HYPNEUMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
HYPNEUMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Hypneuma Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Health And Wellbeing Innovation Centre, Treliske, Truro, TR1 3FF, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer.
Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Plant and machinery 20 % reducing balance
Fixtures and fittings 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2022 2021
Number Number
Monthly average number of persons employed by the Company during the year, including directors 7 3

3. Tangible assets

Plant and machinery Fixtures and fittings Total
£ £ £
Cost
At 01 January 2022 0 0 0
Additions 2,650 13,148 15,798
At 31 December 2022 2,650 13,148 15,798
Accumulated depreciation
At 01 January 2022 0 0 0
Charge for the financial year 530 2,227 2,757
At 31 December 2022 530 2,227 2,757
Net book value
At 31 December 2022 2,120 10,921 13,041
At 31 December 2021 0 0 0

4. Debtors

2022 2021
£ £
Trade debtors 68,903 0
Other debtors 30,345 12
99,248 12

5. Creditors: amounts falling due within one year

2022 2021
£ £
Trade creditors 29,551 0
Taxation and social security 16,281 956
Other creditors 4,000 61,322
49,832 62,278

6. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2022 2021
£ £
within one year 0 5,950

The commitment relates to the rental of the property from which the company operates. There is no commitment at 31 December 2022.

7. Related party transactions

Other related party transactions

2022 2021
£ £
Global Inhalation Equipment Limited 0 57,093
General Anesthetic Services Inc 0 2,501

During the year amounts due to Global Inhalation Equipment Limited of £187,985 and amounts due to General Anesthetic Services Inc of £125,096 were written off. These amounts have been included within other operating income.